Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Cyprus
Cyprus: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 83.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Cyprus, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Cyprus is 83.0%, measured in 2025. That is the highest value across all 18 years on record.
That represents a change of up 1.2% on the previous year and up 2.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Cyprus peaked at 83.0% in 2025 and was at its lowest, 0.0%, in 2008.
Cyprus ranks 104th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 40.5% | 0.0% | 81.0% | 10 |
| 2020s | 80.3% | 74.0% | 83.0% | 6 |
Countries ranked near Cyprus
More health data for Cyprus
- Heat deaths vs projected death rates 1,325 (2090)
- Un projection of annual infant deaths 7 (2100)
- Deaths in armed conflicts by country 0 (2026)
- Deaths in armed conflicts by region 0 (2026)
- Age population, age 25, male, interpolated 8,247 (2025)
- Age population, age 25, female, interpolated 7,986 (2025)
- Age population, age 24, male, interpolated 7,978 (2025)
- Age population, age 24, female, interpolated 7,707 (2025)
- Age population, age 23, male, interpolated 7,758 (2025)
- Age population, age 23, female, interpolated 7,470 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Cyprus?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Cyprus was 83.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Cyprus?
- The highest recorded value was 83.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Cyprus?
- The lowest recorded value was 0.0% in 2008.
- How does Cyprus rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Cyprus ranks 104th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Cyprus?
- Over the last ten years it is up 2.5%. The long-run trend across the full record is volatile.
- Where does this Cyprus data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).